Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1998 Dec;82(12):1387–1392. doi: 10.1136/bjo.82.12.1387

Acanthamoeba keratitis: multicentre survey in England 1992-6

C Radford 1, O Lehmann 1, J Dart 1
PMCID: PMC1722455  PMID: 9930269

Abstract

AIM—To investigate the frequency, outcomes, and risk factors for acanthamoeba keratitis (AK) in England during the past 4 years.
METHODS—An ophthalmologist in 12 of the 14 regional health authorities (RHAs) coordinated identification of patients in their region presenting with AK between 1 October 1992 and 30 September 1996. Clinical and postal patient questionnaire data were analysed.
RESULTS—243 patients (259 eyes) with an AK diagnosis were identified, equating to an annualised incidence of 0.14 per 100 000 individuals. UK resident patients for each year numbered 50, 71, 73, and 32 respectively. Among patients with sufficient data 170/237 (72%) were diagnosed early (within 30 days of presentation), 197/218 (90%) were treated with polyhexamethyl biguanide and/or chlorhexidine, and 40/243 (16%) underwent surgery. Visual acuities of 6/12 or better were achieved by 222/259 (86%) eyes, including 84 eyes of patients under review or lost to follow up. Non-contact lens (CL) wearers were associated with delayed diagnosis, increased need for surgery and a poorer visual outcome (only 10/18 eyes, 56%, achieved 6/12 acuity). 225/243 (93%) patients were CL wearers, and 205/243 (84%) were soft CL (SCL) users. Among SCL user respondents, previously identified risk factors—swimming with CL (47/138, 34%), non-sterile CL rinsing (11/138, 8%), omitted disinfection (85/138, 62%), and chlorine release disinfection (65/138, 47%)—were identified for 125/138 (91%) patients.
CONCLUSIONS—Earlier diagnosis and more effective medical therapy have improved the prognosis for most AK patients. The study demonstrates the highly preventable nature of the disease: 91% of the SCL wearers could have avoided the disease by refraining from inadvisable practices, and a marked fall in frequency was seen after intensive media attention to AK, possibly in conjunction with increasing penetrance of new CL products. Since the frequency of AK appears to be largely determined by the ever changing trends in CL use, continued monitoring is indicated.

 Keywords: keratitis; Acanthamoeba; multicentre survey; England

Full Text

The Full Text of this article is available as a PDF (116.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auran J. D., Starr M. B., Jakobiec F. A. Acanthamoeba keratitis. A review of the literature. Cornea. 1987;6(1):2–26. [PubMed] [Google Scholar]
  2. Bacon A. S., Frazer D. G., Dart J. K., Matheson M., Ficker L. A., Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond) 1993;7(Pt 6):719–725. doi: 10.1038/eye.1993.168. [DOI] [PubMed] [Google Scholar]
  3. Claydon B. E., Efron N. Non-compliance in contact lens wear. Ophthalmic Physiol Opt. 1994 Oct;14(4):356–364. [PubMed] [Google Scholar]
  4. Cohen E. J., Gonzalez C., Leavitt K. G., Arentsen J. J., Laibson P. R. Corneal ulcers associated with contact lenses including experience with disposable lenses. CLAO J. 1991 Jul;17(3):173–176. [PubMed] [Google Scholar]
  5. Devonshire P., Munro F. A., Abernethy C., Clark B. J. Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol. 1993 Jan;77(1):41–45. doi: 10.1136/bjo.77.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Duguid I. G., Dart J. K., Morlet N., Allan B. D., Matheson M., Ficker L., Tuft S. Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology. 1997 Oct;104(10):1587–1592. doi: 10.1016/s0161-6420(97)30092-x. [DOI] [PubMed] [Google Scholar]
  7. Elder M. J., Kilvington S., Dart J. K. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1059–1064. [PubMed] [Google Scholar]
  8. Hay J., Kirkness C. M., Seal D. V., Wright P. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye (Lond) 1994;8(Pt 5):555–563. doi: 10.1038/eye.1994.137. [DOI] [PubMed] [Google Scholar]
  9. Illingworth C. D., Cook S. D., Karabatsas C. H., Easty D. L. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol. 1995 Dec;79(12):1078–1082. doi: 10.1136/bjo.79.12.1078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kilvington S., Larkin D. F. Acanthamoeba adherence to contact lenses and removal by cleaning agents. Eye (Lond) 1990;4(Pt 4):589–593. doi: 10.1038/eye.1990.82. [DOI] [PubMed] [Google Scholar]
  11. Radford C. F., Bacon A. S., Dart J. K., Minassian D. C. Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ. 1995 Jun 17;310(6994):1567–1570. doi: 10.1136/bmj.310.6994.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schein O. D., Glynn R. J., Poggio E. C., Seddon J. M., Kenyon K. R. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. N Engl J Med. 1989 Sep 21;321(12):773–778. doi: 10.1056/NEJM198909213211201. [DOI] [PubMed] [Google Scholar]
  13. Sharma S., Srinivasan M., George C. Acanthamoeba keratitis in non-contact lens wearers. Arch Ophthalmol. 1990 May;108(5):676–678. doi: 10.1001/archopht.1990.01070070062035. [DOI] [PubMed] [Google Scholar]
  14. Stehr-Green J. K., Bailey T. M., Brandt F. H., Carr J. H., Bond W. W., Visvesvara G. S. Acanthamoeba keratitis in soft contact lens wearers. A case-control study. JAMA. 1987 Jul 3;258(1):57–60. [PubMed] [Google Scholar]
  15. Stehr-Green J. K., Bailey T. M., Visvesvara G. S. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989 Apr 15;107(4):331–336. doi: 10.1016/0002-9394(89)90654-5. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES